{"name":"Compumedics Limited","slug":"compumedics","ticker":"CMP","exchange":"ASX","domain":"compumedics.com.au","description":"Compass Minerals International, Inc. provides essential minerals in the United States, Canada, the United Kingdom, and internationally. It operates through two segments, Salt and Plant Nutrition. The Salt segment produces, markets, and sells sodium chloride and magnesium chloride, including rock salt, mechanically and solar evaporated salt, and brine and flake magnesium chloride products; and purchases and sells potassium chloride and calcium chloride to sell as finished products or to blend with sodium chloride to produce specialty products. This segment provides products for use as a deicer for roadways, consumer, and professional use; as an ingredient in chemical production; for water treatment, human, and animal nutrition; and for various other consumer and industrial uses, as well as records management services. The Plant Nutrition segment produces sulfate of potash specialty fertilizers in various grades that are used in broadcast spreaders, direct application, and liquid fertili","hq":"Abbotsford, Australia","founded":1987,"employees":"1800","ceo":"David Burton","sector":"Medical Devices — Neurodiagnostics","stockPrice":30.43,"stockChange":0.22,"stockChangePercent":0.73,"marketCap":"$1.3B","metrics":{"revenue":1291399936,"revenueGrowth":-8.4,"grossMargin":17.5,"rdSpend":0,"netIncome":7100000,"cash":74100000,"dividendYield":0,"peRatio":190.2,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2028-06-01","label":"Somté patent cliff ($10.5M at risk)","drug":"Somté","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-28","type":"earnings","headline":"Compumedics Limited Reports FY2024 Half-Year Results","summary":"The company reported revenue of $14.3 million and a net loss of $2.4 million for the half-year period.","drugName":"","sentiment":"neutral"},{"date":"2023-11-15","type":"deal","headline":"Compumedics Limited Partners with Leading Sleep Clinic","summary":"The company partnered with a leading sleep clinic to promote its sleep diagnostic systems.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxNVF9GVjhuUnRqUnR5WEpzLVZPd2gySXpWOEtEYWVDdGdITlphblVZaXU4cE5RWGFMc0hOZkdTX1VqdDVOZGxCN0VXQkRnSXVMM2pBSUJsX05KS1JSaE9fMnlodUJramU4ODY4RVlZaHQ2Z1pzVmJBMkxxODlra1pfNGVNMkktcm44LTlHbk50akxoYjZsbWlzTkdxUEwxWnNGdS02SldXcUw4NWNl?oc=5","date":"2025-07-03","type":"pipeline","source":"Stockhead","summary":"Compumedics’ dual-helmet brain tech hits a nerve in China’s neuroscience boom - Stockhead","headline":"Compumedics’ dual-helmet brain tech hits a nerve in China’s neuroscience boom","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxObXpvQ0xvd0pEaTJvYkZTWk5ZMkVhcHVTSFJ2d3lYSGtRVVpWVTVSZENvQk9qQUJtS005YWtPbUlnWGtTVUxUd1kyT0tnR0hGX25pYlpKRU5fYkdaQ0Jqc1lEUGdsVzhJR1FNWElTcGxaeFJmLWNyNWRoYXdJRUJ0bkRDaGtsTHlCU195dnZYUzVuQlVSa3p0TzgxM2tSSTQwWFVyZG1tSXpNU1UtdDIwVUtPd1VxRG4tdWNiclVrdw?oc=5","date":"2024-09-09","type":"pipeline","source":"Stockhead","summary":"Alive and Kicking: ‘We are not alone in going through a lull in markets’, says Clinuvel chair - Stockhead","headline":"Alive and Kicking: ‘We are not alone in going through a lull in markets’, says Clinuvel chair","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxOcldfbDFCMm5MMDQtYXMwcTJjY2VfSC1PYlF2aUxodmtCQkYxWXZSR0hQV1hSRnVTM2NIN3I2b2s1OVhVZ1d5THdGUk92cnFsS1k0QUk4Q05sZVlkbnFkRzZWUGUzM1ltb0VTbW04U2VZSHBaM2QyVWFia2ZwZ2xRM3FXX2VZbGtwZUtqTmJCUl9oNFZGZUlXZ1Q1cDUtTW5pai1pWDlpWW9HQ00tWEZTUzYtdE9Oa0JvT0E?oc=5","date":"2023-12-06","type":"regulatory","source":"Proactive Investors","summary":"Compumedics welcomes FDA clearance for Somfit - Proactive Investors","headline":"Compumedics welcomes FDA clearance for Somfit","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiVEFVX3lxTE9NcnBrNDJZU19VeTdSTnpBeGFvZm50dTVGYVppUlJ4anZDZXpVelY0Y3FvcTRBRTU0ZEptX3M5V2NfV2R0OHVKZVZkNklXenZCZ2tfSQ?oc=5","date":"2017-05-29","type":"pipeline","source":"Yahoo Finance Australia","summary":"Compumedics Limited (CMP.AX) stock price, news, quote and history - Yahoo Finance Australia","headline":"Compumedics Limited (CMP.AX) stock price, news, quote and history","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1wFBVV95cUxOemY4bTNlTEZjMkJRQnltMmR2T19PdldnUVZYX1hsNnJubExNY2VDOEJCSC1abmk5b1VsR1lROUU4WFhOTXZaa3ZtVnJIZkNpM0tvWGpiX2tFS2l4dDNOTEo4ZDNVcVhxVjNDc0JKZkZZLUN3eVBCRDBtTmlxQzcxTTItNl9yTWVlcmhWRVpUak1qRjhMTnpVV0ZxQno3cnhEZTg4SkVMMzNMSFhnMXAwcmRDcEhINFJQUGttOVpmTGlwOVp0c1dwTDJkTzd3UmtxN1hKclJEQQ?oc=5","date":"2016-06-29","type":"pipeline","source":"Proactive Investors","summary":"Compumedics Ltd's talks Next Generation Growth in Proactive Q&A Sessions™ - Proactive Investors","headline":"Compumedics Ltd's talks Next Generation Growth in Proactive Q&A Sessions™","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0gFBVV95cUxNdVZxcDR2cUtOckcxWC05YnVZSGgwNVc2NU5ySGgxNzFNOFJVT3hfSlNMQThqcmFuQWF2dGdLV2hrTEFtZ0h3bmFSTVF0T0xHeXIxc2x5VkhCZ1Yzb20zWG9DQlJnWmNlakx5UkZJZUhhMFFWV3pHZkl4UDM1aVNmbkY2d0tGOGY1VERQSnFwUmRBZVlMLUpEbXNscndCZVd6Z01NeEQyRWRvUER2SmMtbHYtTnJHRVBkdTIwbXR3TVJkZ1BDTmxjYUZJY2pscER4Mmc?oc=5","date":"2015-09-14","type":"pipeline","source":"Proactive financial news","summary":"Compumedics Limited secures $2M South Korean distribution contract - Proactive financial news","headline":"Compumedics Limited secures $2M South Korean distribution contract","sentiment":"neutral"}],"patents":[{"drugName":"Somté","drugSlug":"somté","patentNumber":"","type":"Patent Cliff","expiryDate":"2028-06-01","territory":"US","annualRevenue":10500000}],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Natus Medical Incorporated","Medtronic plc","Philips Healthcare"],"therapeuticFocus":["Neurology","Sleep Disorders"],"financials":{"source":"yahoo_finance","revenue":1243900000,"revenuePeriod":"2025-09-30","revenueHistory":[{"period":"2025-09-30","value":1243900000},{"period":"2024-09-30","value":1117400000},{"period":"2023-09-30","value":1204700000},{"period":"2022-09-30","value":1245200000}],"grossProfit":190700000,"grossProfitHistory":[{"period":"2025-09-30","value":190700000},{"period":"2024-09-30","value":195000000},{"period":"2023-09-30","value":232000000},{"period":"2022-09-30","value":199800000}],"rdSpend":null,"rdSpendHistory":[],"sgaSpend":113300000,"operatingIncome":79000000,"operatingIncomeHistory":[{"period":"2025-09-30","value":79000000},{"period":"2024-09-30","value":74200000},{"period":"2023-09-30","value":77400000},{"period":"2022-09-30","value":45400000}],"netIncome":-79800000,"netIncomeHistory":[{"period":"2025-09-30","value":-79800000},{"period":"2024-09-30","value":-206100000},{"period":"2023-09-30","value":10500000},{"period":"2022-09-30","value":-21100000}],"eps":-1.91,"epsHistory":[{"period":"2025-09-30","value":-1.91},{"period":"2024-09-30","value":-4.99},{"period":"2023-09-30","value":0.37},{"period":"2022-09-30","value":-0.73}],"cash":59700000,"cashHistory":[{"period":"2025-09-30","value":59700000},{"period":"2024-09-30","value":20200000},{"period":"2023-09-30","value":38700000},{"period":"2022-09-30","value":46100000}],"totalAssets":1519400000,"totalLiabilities":1285300000,"totalDebt":847700000,"equity":234100000,"operatingCashflow":197700000,"operatingCashflowHistory":[{"period":"2025-09-30","value":197700000},{"period":"2024-09-30","value":14400000},{"period":"2023-09-30","value":106000000},{"period":"2022-09-30","value":120400000}],"capex":-69700000,"capexHistory":[{"period":"2025-09-30","value":-69700000},{"period":"2024-09-30","value":-114200000},{"period":"2023-09-30","value":-154300000},{"period":"2022-09-30","value":-96600000}],"freeCashflow":128000000,"dividendsPaid":0,"buybacks":null,"employees":1800,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[{"sga":26600000,"ebit":34500000,"ebitda":60900000,"period":"2025-12-31","revenue":396100000,"epsBasic":0.43,"netIncome":18600000,"rdExpense":null,"epsDiluted":0.43,"grossProfit":63200000,"operatingIncome":36600000},{"sga":26400000,"ebit":13300000,"ebitda":40000000,"period":"2025-09-30","revenue":227500000,"epsBasic":-0.17,"netIncome":-7200000,"rdExpense":null,"epsDiluted":-0.17,"grossProfit":38400000,"operatingIncome":12000000},{"sga":24000000,"ebit":2700000,"ebitda":25900000,"period":"2025-06-30","revenue":214600000,"epsBasic":-0.41,"netIncome":-17000000,"rdExpense":null,"epsDiluted":-0.41,"grossProfit":41200000,"operatingIncome":16600000},{"sga":29600000,"ebit":-4200000,"ebitda":22300000,"period":"2025-03-31","revenue":494600000,"epsBasic":-0.77,"netIncome":-32000000,"rdExpense":null,"epsDiluted":-0.77,"grossProfit":76800000,"operatingIncome":49900000},{"sga":33300000,"ebit":3000000,"ebitda":29800000,"period":"2024-12-31","revenue":307200000,"epsBasic":-0.57,"netIncome":-23600000,"rdExpense":null,"epsDiluted":-0.57,"grossProfit":34300000,"operatingIncome":500000},{"sga":null,"ebit":null,"ebitda":null,"period":"2024-09-30","revenue":null,"epsBasic":null,"netIncome":null,"rdExpense":null,"epsDiluted":null,"grossProfit":null,"operatingIncome":null}]},"ciks":null,"lastFiledAt":null},"yahoo":{"currentPrice":30.43,"previousClose":30.21,"fiftyTwoWeekHigh":32.27,"fiftyTwoWeekLow":16.4,"fiftyTwoWeekRange":"16.4 - 32.27","fiftyDayAverage":24.79,"twoHundredDayAverage":21.3,"beta":1.19,"enterpriseValue":1968861696,"forwardPE":28.1,"priceToBook":4.66,"priceToSales":0.99,"enterpriseToRevenue":1.52,"enterpriseToEbitda":8.75,"pegRatio":0.12,"ebitda":225100000,"ebitdaMargin":17.4,"freeCashflow":82537504,"operatingCashflow":175300000,"totalDebt":775400000,"debtToEquity":282.8,"currentRatio":2.06,"returnOnAssets":5.2,"returnOnEquity":2.8,"analystRating":"2.3 - Buy","recommendationKey":"buy","numberOfAnalysts":4,"targetMeanPrice":25.75,"targetHighPrice":30,"targetLowPrice":20,"dividendRate":0,"payoutRatio":0,"fiveYearAvgDividendYield":3.44,"exDividendDate":1709856000,"insiderHeldPercent":23.2,"institutionHeldPercent":74.8,"sharesOutstanding":41958348,"floatShares":39333014,"sharesShort":1641315,"shortRatio":3.26,"shortPercentOfFloat":3.9,"epsTrailing":0.16,"epsForward":1.08,"revenuePerShare":30.64,"bookValue":6.54,"officers":[{"age":70,"name":"Dr. Edward C. Dowling Jr., B.Sc., M.Sc., Ph.D.","title":"President, CEO & Director"},{"age":55,"name":"Mr. Peter  Fjellman","title":"Chief Financial Officer"},{"age":53,"name":"Mr. Patrick James Merrin","title":"Chief Operating Officer"},{"age":47,"name":"Ms. Amy  Tills","title":"Chief Human Resources Officer"},{"age":43,"name":"Mr. Benjamin  Nichols","title":"Chief Commercial Officer"},{"age":40,"name":"Ms. Ashley  Ward","title":"Chief Accounting Officer"},{"age":null,"name":"Mr. Brent  Collins","title":"Vice President, Treasurer & Investor Relations"},{"age":null,"name":"Mr. James D. Hughes","title":"VP, General Counsel & Corporate Secretary"}],"industry":"Other Industrial Metals & Mining","irWebsite":"http://phx.corporate-ir.net/phoenix.zhtml?c=148615&p=irol-irhome","website":"https://www.compassminerals.com","phone":"913 344 9200"}}